UbcH10 DN Citations (2)

Originally described in: Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase.
Townsley FM, Aristarkhov A, Beck S, Hershko A, Ruderman JV Proc Natl Acad Sci U S A 1997 Mar 18;94(6):2362-7. PubMed Journal

---

Articles Citing UbcH10 DN

Articles
Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation. Bose MV, Gopisetty G, Selvaluxmy G, Rajkumar T. Int J Radiat Biol. 2012 Sep;88(9):629-34. doi: 10.3109/09553002.2012.702299. Epub 2012 Jul 4. PubMed
Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole. Rawat A, Gopal G, Selvaluxmy G, Rajkumar T. Cell Oncol (Dordr). 2013 Dec;36(6):459-67. doi: 10.1007/s13402-013-0150-8. Epub 2013 Sep 27. PubMed

If you have published an article using this material, please email us at to have your article added to this page.